Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
the patient had COVID; the patient had COVID; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "the patient had COVID". Clinical course: This is the second time patient got Covid. Last time, when she was prescribed Paxlovid, she didn't have any issue getting the medication, but right now, when she went to the pharmacy, and the pharmacist told her that she needs the billing information, so she kind of worried because she didn't have this experience before and she's is sick. She need assistance on how to taken care of it, like, you know, getting the medication for the Paxlovid". The reason for the call was because the patient had Covid for a second time, took Paxlovid previously, and needed assistance. No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.